DHS MIND Metabolomics
NCT03975309 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 417
Last updated 2023-12-05
Summary
The study team will evaluate whether metabolomic signatures of neurocognitive decline trajectories are exacerbated by the presence of type 2 diabetes mellitus (T2D) and whether these signatures contribute in part, to ethnic disparities in cognitive decline between European Americans and African Americans with T2D.
Conditions
Sponsors & Collaborators
-
National Institute on Aging (NIA)
collaborator NIH -
Wake Forest University Health Sciences
lead OTHER
Principal Investigators
-
Nicholette D Allred, PhD · Wake Forest University Health Sciences
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-09-09
- Primary Completion
- 2023-05-23
- Completion
- 2023-05-23
Countries
- United States
Study Locations
More Related Trials
-
Risk Model of Cognitive Impairment in Diabetes
NCT05590442 ·Status: RECRUITING
-
Microbial Determinants of Dementia Risk in Type 2 Diabetics of Mexican Descent
NCT04602650 ·Status: COMPLETED
-
Evaluation and Intervention of Cognitive Function in Patients With Diabetes Mellitus.
NCT05262257 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Brain-derived Neurotrophic Factor and Cogntive Function
NCT01390688 ·Status: UNKNOWN
-
A Decentralized Study on Dietary Influences on Cognitive Functions
NCT05801731 ·Status: COMPLETED ·Phase: NA
-
Utilizing Glycaemic Index: An Investigation of the Glycaemia and Cognition in Type 2 Diabetes
NCT03360604 ·Status: COMPLETED ·Phase: NA
-
Type 2 Diabetes Mellitus as Catalyst for Alzheimer's Disease
NCT02501876 ·Status: COMPLETED
-
The Effects of Some Antihyperglycemic Drugs on Cognitive Function and Risk of Depression of Diabetic Patients
NCT07244770 ·Status: RECRUITING
-
Risk Factors for Type 2 Diabetes Mellitus With Cognitive Impairment: a Cohort Study
NCT05728567 ·Status: ACTIVE_NOT_RECRUITING
-
The Imaging Genetic Study of Type 2 Diabetes and Depression
NCT03564431 ·Status: UNKNOWN
-
Establish Diagnostic Models Based on Olfactory Function and Odor-induced Brain Activation for Diabetes-Related Cognitive Impairment
NCT05543967 ·Status: UNKNOWN
-
Insulin Sensitivity of the Brain in Pathogenesis of Diabetes Mellitus Type 2
NCT00638209 ·Status: UNKNOWN ·Phase: NA
-
Investigating the Insulin Resistance in Individuals With Type 2 Diabetes
NCT06428968 ·Status: RECRUITING ·Phase: NA
-
Molecular and Clinical Profile of Diabetes Mellitus and Its Complications
NCT01105858 ·Status: SUSPENDED
-
Sweet Sensing in Type 2 Diabetes
NCT06804187 ·Status: ENROLLING_BY_INVITATION
-
Insulin Resistance and Accelerated Cognitive Aging
NCT03039647 ·Status: COMPLETED
-
The Diabetes Prevention Program Outcomes Study AD/ADRD Project
NCT05704309 ·Status: ENROLLING_BY_INVITATION
-
The Daytime Circadian Rhythm in Exhaled Volatile Organic Compounds in People Living Without and Diabetes
NCT05984979 ·Status: RECRUITING
-
Chronotype of Patients With Diabetes and Effect on Glycaemic Control
NCT02973412 ·Status: RECRUITING
-
Changing the Natural History of Type 2 Diabetes ("CHANGE" Study)
NCT05040087 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
BDNF Level and val66met Polymorphism of Brain Derived Neurotropic Factor Gene in Patients With T2DM and Depression
NCT05526131 ·Status: COMPLETED ·Phase: NA
-
Carotid Body Function in Type 2 Diabetes Mellitus
NCT05237076 ·Status: COMPLETED ·Phase: NA
-
The Early Warning System for the Diabetic Encephalopathy
NCT02420470 ·Status: RECRUITING
-
The Association Between Cognitive Function and Neuropathy in Individuals With Type 2 Diabetes
NCT06857994 ·Status: COMPLETED
-
Exercise-induced Blood Glucose Response in Patients With Type 2 Diabetes
NCT03335930 ·Status: COMPLETED ·Phase: NA